| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 11/24/2011 | WO2011143721A1 Compositions and methods for treating neurodegenerative disorders |
| 11/24/2011 | WO2011101634A3 Methods of prevention or treatment of triggered inflammatory reactions using tumor necrosis factor alpha antagonist |
| 11/24/2011 | WO2011097581A9 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES |
| 11/24/2011 | WO2011087755A3 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications |
| 11/24/2011 | WO2011054001A3 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 11/24/2011 | WO2011053792A4 Methods and compositions for sustained delivery of drugs |
| 11/24/2011 | WO2011036558A3 Crystalline methylthionium chloride (methylene blue) hydrates |
| 11/24/2011 | US20110288363 Biologically Enhanced Irrigants |
| 11/24/2011 | US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof |
| 11/24/2011 | US20110288176 Ethacrynic acid-containing composition for prevention or treatment of transglutaminase-related diseases and method for prevention or treatment of transglutaminase-related diseases using the same |
| 11/24/2011 | US20110288175 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 11/24/2011 | US20110288173 Use of neboglamine in the treatment of toxicodependency |
| 11/24/2011 | US20110288169 Triterpenoid compounds and methods of use thereof |
| 11/24/2011 | US20110288168 Histone deacetylase inhibitors |
| 11/24/2011 | US20110288161 Methods for treatment of thiol-containing compound deficient conditions |
| 11/24/2011 | US20110288159 Methods of expressing a polypeptide in the brain and nucleic acid constructs capable of same |
| 11/24/2011 | US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis |
| 11/24/2011 | US20110288155 Sirna compounds and methods of use thereof |
| 11/24/2011 | US20110288145 Novel Formulation For L-Tryptophane Comprising Carbidopa/Benserazide |
| 11/24/2011 | US20110288140 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers |
| 11/24/2011 | US20110288139 Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture |
| 11/24/2011 | US20110288138 Orally disintegrating tablets of zolmitriptan and process for preparing the same |
| 11/24/2011 | US20110288137 Sydnonimines-specific dopamine reuptake inhibitors ad their use in treating dopamine related disorders |
| 11/24/2011 | US20110288132 Nicotine and Cocoa Powder Compositions |
| 11/24/2011 | US20110288129 Amide derivatives as trpv1 antagonists |
| 11/24/2011 | US20110288128 Oral Transmucosal Administration of Sufentanil |
| 11/24/2011 | US20110288124 Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 11/24/2011 | US20110288122 Pharmaceutical Compositions and Administrations Thereof |
| 11/24/2011 | US20110288120 Isoquinolinone derivatives as nk3 antagonists |
| 11/24/2011 | US20110288119 Low dose - prov (alpha 7-EVP) |
| 11/24/2011 | US20110288115 Treatment of vagally-mediated spectrum disorders |
| 11/24/2011 | US20110288114 Compositions for the treatment of fibrotic diseases or conditions |
| 11/24/2011 | US20110288113 Method to reduce or elminate the use by a patient of a tolerance-inducing pharamacological agent |
| 11/24/2011 | US20110288112 Method of Providing Sustained Analgesia With Buprenorphine |
| 11/24/2011 | US20110288106 Adenine receptor ligands |
| 11/24/2011 | US20110288105 Eltoprazine for the treatment of l-dopa-induced dyskinesia |
| 11/24/2011 | US20110288103 Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives |
| 11/24/2011 | US20110288098 Novel compounds |
| 11/24/2011 | US20110288097 Pyrrolopyrazine Kinase Inhibitors |
| 11/24/2011 | US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 11/24/2011 | US20110288087 Fused ring compound and use thereof |
| 11/24/2011 | US20110288083 Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase |
| 11/24/2011 | US20110288079 Tannate Compositions, Methods of Making and Methods of Use |
| 11/24/2011 | US20110288075 Pyridazinone Derivatives |
| 11/24/2011 | US20110288074 New adenosine receptor ligands and uses thereof |
| 11/24/2011 | US20110288073 Alpha-Aminocyclolactam Ligands for G-protein Coupled Receptors, and Methods of Using Same |
| 11/24/2011 | US20110288072 Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction |
| 11/24/2011 | US20110288070 Methods for treating cognitive disorders using inhibitors of histone deacetylase |
| 11/24/2011 | US20110288069 Benzodiazepine and Pyridodiazepine Derivatives |
| 11/24/2011 | US20110288067 Pyrrolopyrazine Kinase Inhibitors |
| 11/24/2011 | US20110288066 Phenoxy acetic acid derivatives |
| 11/24/2011 | US20110288060 apparatus and process for producing crystals |
| 11/24/2011 | US20110288059 Neuroactive steroid compositions and methods of use therefor |
| 11/24/2011 | US20110288058 Methods for Preventing or Reducing Colon Carcinogenesis |
| 11/24/2011 | US20110288051 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 11/24/2011 | US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System |
| 11/24/2011 | US20110288030 Paralytic Peptide for Use in Neuromuscular Therapy |
| 11/24/2011 | US20110288029 Method for inhibiting neuronal cell death |
| 11/24/2011 | US20110288028 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 11/24/2011 | US20110288027 Targets, methods, and reagents for diagnosis and treatment of schizophrenia |
| 11/24/2011 | US20110288022 Treatment of depressive disorders |
| 11/24/2011 | US20110288020 Use of VEGF and homologues to treat neuron disorders |
| 11/24/2011 | US20110288017 Apo-lipoprotein propeptide |
| 11/24/2011 | US20110288011 Peptide therapeutic conjugates and uses thereof |
| 11/24/2011 | US20110288004 Viral Sequences and Uses Thereof |
| 11/24/2011 | US20110287114 Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition |
| 11/24/2011 | US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds |
| 11/24/2011 | US20110287106 Cognitive impairment ameliorant |
| 11/24/2011 | US20110287103 Sustained-release formulations of topiramate |
| 11/24/2011 | US20110287101 Rapid release mini-tablets provide analgesia in laboratory animals |
| 11/24/2011 | US20110287100 Galenic Formulations of Organic Compounds |
| 11/24/2011 | US20110287099 Sustained-release formulations of topiramate |
| 11/24/2011 | US20110287097 Pharmaceutical compositions comprising ropinirole |
| 11/24/2011 | US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies |
| 11/24/2011 | US20110287049 Prevention and treatment of amyloidogenic diseases |
| 11/24/2011 | US20110287048 Antigen Specific Tregs and related compositions, methods and systems |
| 11/24/2011 | US20110287040 Materials and methods for treatment of inflammation |
| 11/24/2011 | US20110287033 Use of ferritin to treat iron disorders |
| 11/24/2011 | US20110287032 Novel ctla4-ig immunoadhesins |
| 11/24/2011 | US20110287030 Compositions and methods for diagnosing and treating an inflammation |
| 11/24/2011 | US20110287014 Antibodies directed against calcium channel subunit alpha2/delta and methods using same |
| 11/24/2011 | US20110287008 Inhibition of emmprin to treat multiple sclerosis |
| 11/24/2011 | US20110287005 Monoclonal antibodies against amyloid beta protein and uses thereof |
| 11/24/2011 | US20110287000 Treatment of autoimmune and inflammatory disease |
| 11/24/2011 | US20110286986 Lactoferrin and angiogenin compositions and uses thereof |
| 11/24/2011 | US20110286982 Glucagon analogues |
| 11/24/2011 | US20110286970 Method for treating parkinson's disease |
| 11/24/2011 | US20110286966 Inhibitor of Endogenous Human Interferon-gamma |
| 11/24/2011 | US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use |
| 11/24/2011 | US20110286932 Optical method for the detection of alzheimer's disease |
| 11/24/2011 | US20110286927 ATF4 Inhibitors and Their Use for Neural Protection, Repair, Regeneration, and Plasticity |
| 11/24/2011 | US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 11/24/2011 | CA2816928A1 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles |
| 11/24/2011 | CA2800220A1 Phenylmorpholines and analogues thereof |
| 11/24/2011 | CA2800219A1 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence |
| 11/24/2011 | CA2800161A1 Modulators of 5-ht receptors and methods of use thereof |
| 11/24/2011 | CA2800143A1 Selective hdac inhibitors |
| 11/24/2011 | CA2799744A1 A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
| 11/24/2011 | CA2799556A1 Compounds |
| 11/24/2011 | CA2799337A1 Compounds |